This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
23 February, 2016 ICON Reports Fourth Quarter and Full Year 2015 Results and Issues 2016 Earnings Guidance
09 February, 2016 ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
05 January, 2016 ICON Secures Investment Grade Credit Ratings
16 December, 2015 ICON plc Announces Private Placement of US$350,000,000 of Senior Notes
07 December, 2015 ICON Acquires PMG Research, Inc.
25 November, 2015 ICON Announces the Appointment of Dr. Steve Cutler to Board of Directors
27 October, 2015 ICON Reports Third Quarter 2015
10 September, 2015 ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines
28 July, 2015 ICON Reports Second Quarter 2015
27 July, 2015 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
17 June, 2015 ICON Launches Firecrest Patient Portal to Enhance Education around Informed Consent
28 April, 2015 ICON Reports First Quarter 2015
23 April, 2015 ICON Launches Electronic Informed Consent
23 March, 2015 ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent Processes
09 March, 2015 ICON Launches Medical Device & Diagnostics Research Group
02 March, 2015 ICON Completes Acquisition of MediMedia Pharma Solutions
25 February, 2015 ICON Reports Fourth Quarter and Full Year 2014 Results and Issues 2015 Earnings Guidance
02 February, 2015 ICON to Acquire MediMedia Pharma Solutions
06 November, 2014 ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials
22 October, 2014 ICON Reports Third Quarter 2014 and Increases Earnings Guidance
Displaying 61 - 80 of 279


Search Investor